ClinicalTrials.gov
ClinicalTrials.gov Menu

Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris (2011-00500-15)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01595997
Recruitment Status : Completed
First Posted : May 10, 2012
Last Update Posted : January 8, 2013
Sponsor:
Information provided by (Responsible Party):
Delenex Therapeutics AG

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2012
  Actual Study Completion Date : October 2012